SCHEMBL5079802

SCHEMBL5079802

CC(c1cc2cc(Cl)ccc2[nH]1)N(C)C(=O)/C=C/c1cnc2c(c1)CN(C)CC(=O)N2

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
IDH1 O75874 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5079806 1.00 HRH4 (0.38) HRH4HRH3IDH1
Hydrochloric Acid SCHEMBL1253917 0.99 HRH4 (0.37) HRH4HRH3IDH1
Hydrochloric Acid SCHEMBL1253916 0.99 HRH4 (0.37) HRH4HRH3IDH1
SCHEMBL5079057 0.90
SCHEMBL5079061 0.90
Hydrochloric Acid SCHEMBL1253265 0.89
Hydrochloric Acid SCHEMBL1253925 0.89
SCHEMBL5079049 0.83
SCHEMBL5079052 0.83
Hydrochloric Acid SCHEMBL1251820 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575951-B1 HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY DEBIOPHARM INT SA (CH) 2014-06-25 EP claimed
EP-1608377-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF FAB I AND FURTHER ANTIBIOTICS AFFINIUM PHARM INC (CA) 2008-10-01 EP claimed